215 related articles for article (PubMed ID: 19237648)
21. Molecular characterization of para-aminosalicylic acid resistant
Luo M; Li K; Zhang H; Yan X; Gu J; Zhang Z; Chen Y; Li J; Wang J; Chen Y
Infect Drug Resist; 2019; 12():2269-2275. PubMed ID: 31440065
[TBL] [Abstract][Full Text] [Related]
22. Deletion of
Yang SS; Hu YB; Wang XD; Gao YR; Li K; Zhang XE; Chen SY; Zhang TY; Gu J; Deng JY
Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28717039
[TBL] [Abstract][Full Text] [Related]
23. Para-aminosalicylic acid acts as an alternative substrate of folate metabolism in Mycobacterium tuberculosis.
Chakraborty S; Gruber T; Barry CE; Boshoff HI; Rhee KY
Science; 2013 Jan; 339(6115):88-91. PubMed ID: 23118010
[TBL] [Abstract][Full Text] [Related]
24. Role of Whole-Genome Sequencing in Characterizing the Mechanism of Action of
Satta G; Witney AA; Begum N; Ortiz Canseco J; Boa AN; McHugh TD
Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32571810
[No Abstract] [Full Text] [Related]
25. Role of mutations in dihydrofolate reductase DfrA (Rv2763c) and thymidylate synthase ThyA (Rv2764c) in Mycobacterium tuberculosis drug resistance.
Köser CU; Veerapen-Pierce RN; Summers DK; Archer JA
Antimicrob Agents Chemother; 2010 Oct; 54(10):4522-3; author reply 5423-5. PubMed ID: 20852189
[No Abstract] [Full Text] [Related]
26. para-Aminosalicylic acid is a prodrug targeting dihydrofolate reductase in Mycobacterium tuberculosis.
Zheng J; Rubin EJ; Bifani P; Mathys V; Lim V; Au M; Jang J; Nam J; Dick T; Walker JR; Pethe K; Camacho LR
J Biol Chem; 2013 Aug; 288(32):23447-56. PubMed ID: 23779105
[TBL] [Abstract][Full Text] [Related]
27. Contribution of dfrA and inhA mutations to the detection of isoniazid-resistant Mycobacterium tuberculosis isolates.
Ho YM; Sun YJ; Wong SY; Lee AS
Antimicrob Agents Chemother; 2009 Sep; 53(9):4010-2. PubMed ID: 19581462
[TBL] [Abstract][Full Text] [Related]
28. Decreased Methylenetetrahydrofolate Reductase Activity Leads to Increased Sensitivity to
Yu JF; Xu JT; Yang SS; Gao MN; Si HR; Xiong DY; Gu J; Wu ZL; Zhou J; Deng JY
Antimicrob Agents Chemother; 2022 Jan; 66(1):e0146521. PubMed ID: 34780266
[TBL] [Abstract][Full Text] [Related]
29. Knocking out salicylate biosynthesis genes in Mycobacterium smegmatis induces hypersensitivity to p-aminosalicylate (PAS).
Nagachar N; Ratledge C
FEMS Microbiol Lett; 2010 Oct; 311(2):193-9. PubMed ID: 20735479
[TBL] [Abstract][Full Text] [Related]
30. Rates and mechanisms of resistance development in Mycobacterium tuberculosis to a novel diarylquinoline ATP synthase inhibitor.
Huitric E; Verhasselt P; Koul A; Andries K; Hoffner S; Andersson DI
Antimicrob Agents Chemother; 2010 Mar; 54(3):1022-8. PubMed ID: 20038615
[TBL] [Abstract][Full Text] [Related]
31. Usefulness of resistant gene markers for predicting treatment outcome on second-line anti-tuberculosis drugs.
Leung KL; Yip CW; Yeung YL; Wong KL; Chan WY; Chan MY; Kam KM
J Appl Microbiol; 2010 Dec; 109(6):2087-94. PubMed ID: 20854453
[TBL] [Abstract][Full Text] [Related]
32. Mutations of folC cause increased susceptibility to sulfamethoxazole in Mycobacterium tuberculosis.
Wang R; Li K; Yu J; Deng J; Chen Y
Sci Rep; 2021 Jan; 11(1):1352. PubMed ID: 33446754
[TBL] [Abstract][Full Text] [Related]
33. Association of ubiA mutations and high-level of ethambutol resistance among Mycobacterium tuberculosis Thai clinical isolates.
Tulyaprawat O; Chaiprasert A; Chongtrakool P; Suwannakarn K; Ngamskulrungroj P
Tuberculosis (Edinb); 2019 Jan; 114():42-46. PubMed ID: 30711156
[TBL] [Abstract][Full Text] [Related]
34. Analysis of rrs gene mutations in amikacin resistant clinical isolates of Mycobacterium tuberculosis from Khyber Pakhtunkhwa, Pakistan.
Ahmad K; Ahmad Z; Somayya R; Ali A; Rahat S
Microb Pathog; 2017 Jul; 108():66-70. PubMed ID: 28479509
[TBL] [Abstract][Full Text] [Related]
35. Variants of katG, inhA and nat genes are not associated with mutations in efflux pump genes (mmpL3 and mmpL7) in isoniazid-resistant clinical isolates of Mycobacterium tuberculosis from India.
Unissa AN; Dusthackeer VNA; Kumar MP; Nagarajan P; Sukumar S; Kumari VI; Lakshmi AR; Hanna LE
Tuberculosis (Edinb); 2017 Dec; 107():144-148. PubMed ID: 29050763
[TBL] [Abstract][Full Text] [Related]
36. Rifampin-resistance-associated mutations in the rifampin-resistance-determining region of the
Guo Y; Cao X; Yang J; Wu X; Liu Y; Wan B; Hu L; Wang H; Yu F
J Med Microbiol; 2021 Mar; 70(3):. PubMed ID: 33507146
[No Abstract] [Full Text] [Related]
37. Structural Insights into Mycobacterium tuberculosis Rv2671 Protein as a Dihydrofolate Reductase Functional Analogue Contributing to para-Aminosalicylic Acid Resistance.
Cheng YS; Sacchettini JC
Biochemistry; 2016 Feb; 55(7):1107-19. PubMed ID: 26848874
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of gyrA and B gene mutations in fluoroquinolone-resistant and -sensitive clinical isolates of Mycobacterium tuberculosis and their relationship with MIC of ofloxacin.
Singh P; Jain A; Dixit P; Prakash S; Jaiswal I; Venkatesh V; Singh M
J Antibiot (Tokyo); 2015 Jan; 68(1):63-6. PubMed ID: 25052485
[TBL] [Abstract][Full Text] [Related]
39. Performance of Sequencing in Predicting Ofloxacin Resistance in
Wang Z; Xie T; Mu C; Sun R; Wang C; Zhao H; Ju H
Ann Clin Lab Sci; 2018 Jan; 48(1):69-74. PubMed ID: 29530999
[TBL] [Abstract][Full Text] [Related]
40. Comparison of clinical isolates and in vitro selected mutants reveals that tlyA is not a sensitive genetic marker for capreomycin resistance in Mycobacterium tuberculosis.
Engström A; Perskvist N; Werngren J; Hoffner SE; Juréen P
J Antimicrob Chemother; 2011 Jun; 66(6):1247-54. PubMed ID: 21427106
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
